Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

BOISE, Idaho — Lawyers argued during a motions hearing Wednesday over key issues that will shape the trial of the man accused of killing four University of Idaho students, as the defense also ...

With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

April 9, 2025 | David Ferreira talks to C. Michael Gibson about the latest data showing patients don't need to fast ahead of cardiac catheterization. Receive the the latest news, research, and ...

Weinstein's second sexual assault trial is set to begin next week. Harvey Weinstein was back in court on Wednesday with less than a week before the start of his second New York sex assault trial.

Lawyers for Massachusetts murder suspect Karen Read are asking Supreme Court Justice Ketanji Brown Jackson to put her trial on hold until after the nation's highest court considers her petition to ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...

The most popular GLP-1 agent today is semaglutide, the active ingredient in type 2 diabetes medication Ozempic and the higher ...

A smaller percentage of participants using semaglutide had lost 15% to 25% of their weight or more at this point in the trial. Semaglutide also reduced major cardiovascular events — including ...